Literature DB >> 25739918

Evaluation of the characteristics of the enzyme-linked immunospot assay for diagnosis of active tuberculosis in China.

Linchuan Wang1, Yan Yu2, Wei Chen1, Jin Feng1, Jinyuan Wang1, Heping Zhao3, Lietin Ma1, Bo Yang1, Yanfen Ma1, Pei Dang1.   

Abstract

The purpose of this study was to evaluate the characteristics of the T-SPOT.TB test for the diagnosis of active tuberculosis (ATB) and to distinguish ATB from other diseases using a receiver operating characteristic (ROC) curve. A total of 535 patients with suspected active tuberculosis were enrolled in the study and divided into ATB and nonactive tuberculosis (NATB) groups, as well as pulmonary tuberculosis (PTB) and extrapulmonary tuberculosis (EPTB) subgroups. The sensitivity, specificity, positive predictive value, negative predictive value, positive likelihood ratio, and negative likelihood ratio of the T-SPOT.TB test for the diagnosis of ATB were 84.95%, 85.12%, 82.94%, 86.93%, 5.71, and 0.18, respectively. The median number of spot-forming cells (SFCs) in the ATB group was higher than that in the NATB group (71 versus 1; P < 0.0001). The sensitivities in the PTB and EPTB subgroups were 92.31% and 81.77%. The areas under the curve (AUC) for the diagnosis of ATB using the T-SPOT.TB, early secreted antigenic target 6 (ESAT-6), and culture filtrate protein 10 (CFP-10) were 0.906, 0.884, and 0.877, respectively. A cutoff of 42.5 SFCs for ATB yielded a positive predictive value of 100%. Our study shows that the T-SPOT.TB test is useful for the diagnosis of ATB. Utilizing an ROC curve to select an appropriate cutoff made it possible to discriminate ATB from NATB.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25739918      PMCID: PMC4412931          DOI: 10.1128/CVI.00023-15

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN: 1556-679X


  19 in total

1.  Use in routine clinical practice of two commercial blood tests for diagnosis of infection with Mycobacterium tuberculosis: a prospective study.

Authors:  Giovanni Ferrara; Monica Losi; Roberto D'Amico; Pietro Roversi; Roberto Piro; Marisa Meacci; Barbara Meccugni; Ilaria Marchetti Dori; Alessandro Andreani; Barbara Maria Bergamini; Cristina Mussini; Fabio Rumpianesi; Leonardo M Fabbri; Luca Richeldi
Journal:  Lancet       Date:  2006-04-22       Impact factor: 79.321

2.  Rapid diagnosis of tuberculous meningitis by T cell-based assays on peripheral blood and cerebrospinal fluid mononuclear cells.

Authors:  Sung-Han Kim; Oh-Hyun Cho; Su-Jin Park; Eun Mi Lee; Mi-Na Kim; Sang-Oh Lee; Sang-Ho Choi; Yang Soo Kim; Jun Hee Woo; Sang-Ahm Lee; Joong Koo Kang
Journal:  Clin Infect Dis       Date:  2010-05-15       Impact factor: 9.079

3.  Effect of delay in analysis on neonatal cerebrospinal fluid parameters.

Authors:  N T Rajesh; Sourabh Dutta; Rajendra Prasad; Anil Narang
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2009-08-10       Impact factor: 5.747

4.  Are interferon-γ release assays useful for diagnosing active tuberculosis in a high-burden setting?

Authors:  D I Ling; M Pai; V Davids; L Brunet; L Lenders; R Meldau; G Calligaro; B Allwood; R van Zyl-Smit; J Peter; E Bateman; R Dawson; K Dheda
Journal:  Eur Respir J       Date:  2011-02-24       Impact factor: 16.671

5.  Evaluation of a new tuberculosis-related interferon gamma release assay for tuberculosis infection diagnosis in Huzhou, eastern China.

Authors:  Fuchu Qian; Weihong Wang; Zhihong Qiu; Yiqun Shen; Jiangfang He; Dongli Li; Jing Zhong; Licheng Dai
Journal:  Indian J Pathol Microbiol       Date:  2013 Apr-Jun       Impact factor: 0.740

6.  [Report on fourth national epidemiological sampling survey of tuberculosis].

Authors:  Hongjin Duanmu
Journal:  Zhonghua Jie He He Hu Xi Za Zhi       Date:  2002-01

7.  Evaluation of gamma interferon release assays using Mycobacterium tuberculosis antigens for diagnosis of latent and active tuberculosis in Mycobacterium bovis BCG-vaccinated populations.

Authors:  Shu Zhang; Lingyun Shao; Ling Mo; Jiazhen Chen; Feifei Wang; Chengyan Meng; Min Zhong; Lihua Qiu; Meiying Wu; Xinhua Weng; Wenhong Zhang
Journal:  Clin Vaccine Immunol       Date:  2010-10-13

8.  Indeterminate test results of T-SPOT.TB performed under routine field conditions.

Authors:  P Beffa; A Zellweger; J-P Janssens; P Wrighton-Smith; J-P Zellweger
Journal:  Eur Respir J       Date:  2007-12-05       Impact factor: 16.671

9.  Clinical Utility of Two Interferon-gamma Release Assays on Pleural Fluid for the Diagnosis of Tuberculous Pleurisy.

Authors:  Ji Young Kang; Chin Kook Rhee; Na Hyun Kang; Ju Sang Kim; Hyoung-Kyu Yoon; Jeong Sup Song
Journal:  Tuberc Respir Dis (Seoul)       Date:  2012-09-28

10.  Interferon-gamma release assay performance in pulmonary and extrapulmonary tuberculosis.

Authors:  Yun Feng; Ni Diao; Lingyun Shao; Jing Wu; Shu Zhang; Jialin Jin; Feifei Wang; Xinhua Weng; Ying Zhang; Wenhong Zhang
Journal:  PLoS One       Date:  2012-03-13       Impact factor: 3.240

View more
  7 in total

1.  Analysis of Factors Influencing Diagnostic Accuracy of T-SPOT.TB for Active Tuberculosis in Clinical Practice.

Authors:  Lifan Zhang; Xiaochun Shi; Yueqiu Zhang; Yao Zhang; Feifei Huo; Baotong Zhou; Guohua Deng; Xiaoqing Liu
Journal:  Sci Rep       Date:  2017-08-10       Impact factor: 4.379

2.  Utility of T-cell interferon-γ release assays for the diagnosis of female genital tuberculosis in a tertiary referral hospital in Beijing, China.

Authors:  Xiaoqing Liu; Sainan Bian; Xinhe Cheng; Wenze Wang; Qinjie Tian; Lifan Zhang; Yueqiu Zhang; Xiaochun Shi; Yao Zhang; Zhiyong Liang
Journal:  Medicine (Baltimore)       Date:  2016-11       Impact factor: 1.889

3.  Factors associated with negative T-SPOT.TB results among smear-negative tuberculosis patients in China.

Authors:  Wanli Kang; Meiying Wu; Kunyun Yang; A Ertai; Shucai Wu; Shujun Geng; Zhihui Li; Mingwu Li; Yu Pang; Shenjie Tang
Journal:  Sci Rep       Date:  2018-03-09       Impact factor: 4.379

4.  Evaluation of a New IFN-γ Release Assay for Rapid Diagnosis of Active Tuberculosis in a High-Incidence Setting.

Authors:  Gen Li; Feng Li; Hui-Min Zhao; Han-Li Wen; Hai-Cong Li; Chun-Ling Li; Ping Ji; Peng Xu; Kang Wu; Zhi-Dong Hu; Shui-Hua Lu; Douglas B Lowrie; Jian-Xin Lv; Xiao-Yong Fan
Journal:  Front Cell Infect Microbiol       Date:  2017-04-11       Impact factor: 5.293

5.  Clinical evaluation of the T-SPOT.TB test for detection of tuberculosis infection in northeastern Guangdong Province, China.

Authors:  Hua Zhong; Heming Wu; Zhikang Yu; Qunji Zhang; Qingyan Huang
Journal:  J Int Med Res       Date:  2020-05       Impact factor: 1.671

6.  Polymorphism of MPT64 and PstS1 in Mycobacterium tuberculosis is not likely to affect relative immune reaction in human.

Authors:  Tongyang Xiao; Yi Jiang; Guilian Li; Hui Pang; Lili Zhao; Xiuqin Zhao; Kanglin Wan
Journal:  Medicine (Baltimore)       Date:  2019-12       Impact factor: 1.889

7.  Factors associated with differential T cell responses to antigens ESAT-6 and CFP-10 in pulmonary tuberculosis patients.

Authors:  Shengsheng Liu; Meiying Wu; Ertai A; Shucai Wu; Shujun Geng; Zhihui Li; Mingwu Li; Liang Li; Yu Pang; Wanli Kang; Shenjie Tang
Journal:  Medicine (Baltimore)       Date:  2021-02-26       Impact factor: 1.817

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.